Abstract
Brucellosis is the most common bacterial zoonotic infection causing human infections worldwide. Although the disease in domestic animals has been controlled in most developed countries, human brucellosis remains an endemic public health threat in several parts of the world, affecting especially the pediatric population. The aim of this chapter is to summarize the epidemiology, pathogenesis, clinical features, diagnosis, and treatment of childhood brucellosis, and discuss the public health agenda for eradicating the disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Moreno E, Stackebrandt E, Dorsch M, Wolters J, Busch M, Mayer H. Brucella abortus 16 S rRNA and lipid A reveal a phylogenetic relationship with members of the alpha-2 subdivision of the class proteobacteria. J Bacteriol 1990;172:3569–3576.
Maquart M, Zygmunt MS, Cloekaert A. Marine mammal Brucella isolates with different genomic characteristics display differential response with infecting human macrophages in culture. Microbes Infect 2009;11:361–366.
Moreno E, Cloeckaert A, Moriyon I. Brucella evolution and taxonomy. Vet Microbiol 2002;90:209–227.
D’Anastasio R, Staniscia T, Milia ML, Manzoli L, Capasso L. Origin, evolution and epidemiology of brucellosis. Epidemiol Infect 2010, in press.
Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Eng J Med 2005;352:2325–2336.
Franco MP, Mulder M, Gilman RH, Smits HL. Human brucellosis. Lancet Infect Dis 2007;7:775–786.
Yagupsky P. Neonatal brucellosis: rare and preventable. Ann Trop Paediatr 2010;30:177–179.
Mesner O, Riesenberg K, Biliar N, Borstein E, Bouhnik L, Peled N, Yagupsky P. The many faces of human-to-human transmission of brucellosis: congenital infection and outbreak of nosocomial disease related to an unrecognized clinical case. Clin Infect Dis 2007;45:e135–140.
Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis 2006;6:91–99.
Khuri-Bulos NA, Daoud AH, Azab SM. Treatment of childhood brucellosis: results of a prospective trial on 113 children. Pediatr Infect Dis 1990;12:377–381.
Yagupsky P, Peled N, Riesenberg K, Banai M. Exposure of hospital personnel to Brucella melitensis and occurrence of laboratory-acquired disease in an endemic area. Scand J of Infect Dis 2000;32:31–35.
Her M, Cho DH, Kang SI, Lim JS, Kim HJ, Cho YS, Hwqng IY, Lee T, Jung SC, Yoo HS. Outbreak of brucellosis in domestic elk in Korea. Zoonoses Public Health 2010;57:155–161.
Yagupsky P, Baron EJ. Laboratory-exposures to brucellae and implications for bioterrorism. Emerg Infect Dis 2005;11:1180–1185.
Dornand J, Gross A, Lafont V, Liautard J, Liautard P. The innate immune response against Brucella in humans. Veterinary Microbiol. 2002;90:383–394.
Street L, Grant WW, Alva JD. Brucellosis in childhood. Pediatrics 1975;55:416–421.
Tanir G, Tufecki SB, Tuygun N. Presentation, complications and treatment outcome of brucellosis in Turkish children. Pediatr International 2009;51:114–119.
Press J, Buskila D, Yagupsky P. Leukocyte count in the synovial fluid of children with culture-proven brucellar arthritis. Clin Rheumatol 2002;21:191–193.
Tsolia M, Drakonaki S, Messaritaki A, Farmakakis T, Kostaki M, Tsapra H, Karpathios T. Clinical features, complications and treatment outcome of childhood brucellosis in central Greece. J Infect 2001;44:257–262.
Gedalia A, Watenberg N, Rotschild M. Childhood brucellosis in the Negev. Harefuah 1990;119:313–315.
Al-Eissa YA, Kambal AM, Al-Nasser MN, Al-Habib SA, Al-Fawaz IM, Al-Zamil FA. Childhood brucellosis; a study of 102 cases. Pediatr Infect Dis 1990;9:74–79.
Gur A, Geyik MF, Dikici B, Nas K, Cevik R, Sarac J, Hosoglu S. Complications of brucellosis in different age groups: a study of 283 cases in Southeastern Anatolia in Turkey. Yonsei Med J 2003;44:33–44.
Yinnon AM, Morali GA, Goren A, Rudensky B, Isacsohn M, Michel J, Hershko C. Effect of age and duration of disease on the clinical manifestations of brucellosis: A study of 73 consecutive patients in Israel. Israel J Med Sci 1993;29:11–16.
Al-Eissa, Kambal AM, Alrabeeah AA, Abdullah AMA, Al-Jurayyan NA, Al-Jishi NM. Osteoarticular brucellosis in children. Ann Rheum Dis 1990; 49:896–900.
Yagupsky P. Detection of brucellae in blood cultures. J Clin Microbiol 1999;37:3437–3442.
Orduña A, Almaraz A, Prado A, Gutierrez P, GarciaPascual A, Dueñas A, Cuervo M, Abad R, Hernandez B, Lorenzo B, Bratos MA, RodriguezTorres A. Evaluation of an inmunocapture-agglutination test (Brucellacapt) for serodiagnosis of human brucellosis. J Clin Microbiol 2000;38:4000–4005.
Araj GF. Update on laboratory diagnosis of human brucellosis. Int J Antimicrob Agents 2010; (in press).
Ruiz-Mesa JD, Sanchez-Gonzalez J, Reguera JM, Martin L, Lopez-Palmero S, Colmenero JD. Rose Bengal test: diagnostic yield and use for the rapid diagnosis of human brucellosis in emergency departments in endemic areas. Clin Microbiol Infect 2005;11:221–225.
Navarro E, Escribano J, Fernandeez J, Solera J. Comparison of three different PCR methods for detectiomn of Brucella spp in human blood samples. FEMS Immunol Med Microbiol 2002;34:147–151.
Vrioni G, Pappas G, Privali E, Gartzonika C, Levidiotou S. An eternal microbe: Brucella DNA load persists for years after clinical cure. Clin Infect Dis 2008;46:e131–136.
Ariza J, Bosch Gudiol F, Liñares J, Viladrich PF, Martin R. Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis. Antimicrob Agents Chemother 1986;30:958–960.
WrightValderas M, Barrow WW. Establishment of a method for evaluating intracellular antibiotic efficacy in Brucella abortus-infected Mono Mac 6 monocytes. J Antimicrob Chemother 2008;61:28–34.
Treatment of brucellosis in humans. In: Brucellosis in humans and animals. Food and Agriculture Organization of the United Nations, World Organization for Animal Health, World Health Organization. 2006; pp. 36–41.
Skalsky K, Yahav D, Bishara J, Pitlik S, Leibovici L, Paul M. Treatment of human brucellosis: systemic review and meta-analysis of randomized controlled trials. Br Med J 2008;336:701–704.
Solera J, Martinez-Alfaro E, Espinosa A, Castillejos ML, Geijo P, Rodriguez-Zapata M. Multivariate model for predicting relapse in human brucellosis. J Infect 1998;36:85–92.
Abramson O, Rosenvasser Z, Block C, Dagan R. Detection and treatment of brucellosis by screening a population at risk. Pediatr Infect Dis 1991;10:434–438.
Almuneef MA, Memish ZA, Balkhy HH, Alotaibi B, Algoda S, Abbas M, Alsubaie S. Importance of screening household members of acute brucellosis cases in endemic areas. Epidemiol Infect 2004;132:533–540.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Yagupsky, P. (2012). Pediatric Brucellosis: An (Almost) Forgotten Disease. In: Curtis, N., Finn, A., Pollard, A. (eds) Hot Topics in Infection and Immunity in Children VIII. Advances in Experimental Medicine and Biology, vol 719. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-0204-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0204-6_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-0203-9
Online ISBN: 978-1-4614-0204-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)